These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Human gain-of-function STAT1 mutation disturbs IL-17 immunity in mice. Tamaura M; Satoh-Takayama N; Tsumura M; Sasaki T; Goda S; Kageyama T; Hayakawa S; Kimura S; Asano T; Nakayama M; Koseki H; Ohara O; Okada S; Ohno H; Kobayashi M Int Immunol; 2020 Apr; 32(4):259-272. PubMed ID: 31867619 [TBL] [Abstract][Full Text] [Related]
26. Chronic Candida infection, bronchiectasis, immunoglobulin abnormalities, and stunting: a case report of a natural mutation of STAT1 (c.986C>G) in an adolescent male. Yu Y; Xu F; Shen H; Wu J BMC Infect Dis; 2021 Jan; 21(1):38. PubMed ID: 33413180 [TBL] [Abstract][Full Text] [Related]
27. Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis. Bloomfield M; Zentsova I; Milota T; Sediva A; Parackova Z Front Immunol; 2022; 13():983977. PubMed ID: 36172362 [TBL] [Abstract][Full Text] [Related]
28. [Hemophagocytic lymphohistiocytosis as a manifestation of visceral leishmaniasis]. Suková M; Starý J; Housková J; Nohýnková E Cas Lek Cesk; 2002 Sep; 141(18):581-4. PubMed ID: 12422569 [TBL] [Abstract][Full Text] [Related]
29. Common variable immunodeficiency, impaired neurological development and reduced numbers of T regulatory cells in a 10-year-old boy with a STAT1 gain-of-function mutation. Kobbe R; Kolster M; Fuchs S; Schulze-Sturm U; Jenderny J; Kochhan L; Staab J; Tolosa E; Grimbacher B; Meyer T Gene; 2016 Jul; 586(2):234-8. PubMed ID: 27063510 [TBL] [Abstract][Full Text] [Related]
30. Identification of a distinct subset of disease-associated gain-of-function missense mutations in the STAT1 coiled-coil domain as system mutants. Petersen J; Staab J; Bader O; Buhl T; Ivetic A; Meyer T Mol Immunol; 2019 Oct; 114():30-40. PubMed ID: 31336247 [TBL] [Abstract][Full Text] [Related]
31. Case report: Myocarditis in congenital STAT1 gain-of function. Staels F; Roosens W; Giovannozzi S; Moens L; Bogaert J; Iglesias-Herrero C; Gijsbers R; Bossuyt X; Frans G; Liston A; Humblet-Baron S; Meyts I; Van Aelst L; Schrijvers R Front Immunol; 2023; 14():1095595. PubMed ID: 37020552 [TBL] [Abstract][Full Text] [Related]
32. Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation. Moriya K; Suzuki T; Uchida N; Nakano T; Katayama S; Irie M; Rikiishi T; Niizuma H; Okada S; Imai K; Sasahara Y; Kure S Int J Hematol; 2020 Aug; 112(2):258-262. PubMed ID: 32180118 [TBL] [Abstract][Full Text] [Related]
33. Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC). Zheng J; van de Veerdonk FL; Crossland KL; Smeekens SP; Chan CM; Al Shehri T; Abinun M; Gennery AR; Mann J; Lendrem DW; Netea MG; Rowan AD; Lilic D Eur J Immunol; 2015 Oct; 45(10):2834-46. PubMed ID: 26255980 [TBL] [Abstract][Full Text] [Related]